Functional analysis of Survivin splice variants in synovium of rheumatoid arthritis using genome editing
Project/Area Number |
19K18499
|
Research Category |
Grant-in-Aid for Early-Career Scientists
|
Allocation Type | Multi-year Fund |
Review Section |
Basic Section 56020:Orthopedics-related
|
Research Institution | Hiroshima University |
Principal Investigator |
Mokuda Sho 広島大学, 病院(医), 講師 (80837162)
|
Project Period (FY) |
2019-04-01 – 2023-03-31
|
Project Status |
Discontinued (Fiscal Year 2022)
|
Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2022: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2021: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2020: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2019: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
|
Keywords | 関節リウマチ / 炎症 / 細胞増殖 / 滑膜線維芽細胞 / サバイビン / スプライスバリアント / ゲノム編集 |
Outline of Research at the Start |
関節リウマチ(RA)は、骨・軟骨の破壊を伴う全身性の滑膜炎が主体となる自己免疫疾患である。RAの滑膜組織は病的な増殖能を持つが、これまでの研究からこの原因としてがん原遺伝子であるサバイビンの関与が想定された。サバイビンがRAにおいてどのような機能を有するのかを、ゲノム編集法CRISPR/Cas9を用いて遺伝子レベルで証明し、RAの滑膜増殖コントロールに有効な新規の治療標的を開発することを目指す。
|
Outline of Final Research Achievements |
The applicants aimed to elucidate the proliferative potential of synovium in arthritis from the viewpoint of apoptosis, chemotaxis and its functional relationship with inflammation. They aimed to develop previously unidentified factors by comprehensive gene expression analysis using RNA-seq. In synovial fibroblasts stimulated by the proinflammatory cytokine IL-1β, they found decreased gene expression of apoptosis-promoting factors. It was also confirmed that blood coagulation Factor XIII increased the expression of apoptosis inhibitory factor and chemokine genes.
|
Academic Significance and Societal Importance of the Research Achievements |
本研究は、関節リウマチ(RA)の病態の中心である関節滑膜・滑膜線維芽細胞について、病態の解明を目的とした研究である。RAにおける滑膜線維芽細胞の特徴として、炎症性サイトカインの産生能、及び、旺盛な増殖能が挙げられる。本研究で得られた結果は、その病態を分子生物学的に説明することを可能にしており、炎症に伴う滑膜増殖の分子メカニズムを表現することでRAの病態解明に寄与すると考えられた。
|
Report
(4 results)
Research Products
(15 results)
-
-
-
-
[Journal Article] Nailfold capillaries and myositis specific antibodies in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis2021
Author(s)
Sugimoto, T. Mokuda, S. Kohno, H. Ishitoku, M. Araki, K. Watanabe, H. Tokunaga, T. Yoshida, Y. Hirata, S. Sugiyama, E.
-
Journal Title
Rheumatology (Oxford)
Volume: -
Issue: 5
Pages: 2006-2015
DOI
Related Report
Peer Reviewed
-
[Journal Article] C-reactive protein and ground-glass opacity as predictors for intractable interstitial lung disease in patients with systemic sclerosis under cyclophosphamide treatment regardless of concomitant glucocorticoids2021
Author(s)
Yusuke Yoshida, Tomohiro Sugimoto, Yohei Hosokawa, Harumichi Suma, Hiroki Kobayashi, Michinori Ishitoku, Hiroki Kohno, Tadahiro Tokunaga, Hirofumi Watanabe, Sho Mokuda, Takaki Nojima, Shintaro Hirata, Eiji Sugiyama
-
Journal Title
Modern Rheumatology
Volume: ahead of print
Issue: 1
Pages: 141-148
DOI
Related Report
Peer Reviewed
-
-
-
[Journal Article] Asymptomatic coronary aneurysms in a patient with eosinophilic granulomatosis with polyangiitis who developed a digital gangrene2021
Author(s)
Mayu Sato, Yusuke Yoshida, Tomohiro Sugimoto, Shinji Kishimoto, Takuji Omoto, Hirofumi Watanabe, Tadahiro Tokunaga, Kazutoshi Yukawa, Hiroki Kohno, Sho Mokuda, Takaki Nojima, Shintaro Hirata, Eiji Sugiyama
-
Journal Title
Modern Rheumatology Case Reports
Volume: 5
Issue: 1
Pages: 130-136
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Lower CH50 as a predictor for intractable or recurrent lupus enteritis: A retrospective observational study2021
Author(s)
Yusuke Yoshida, Takuji Omoto, Hiroki Kohno, Tadahiro Tokunaga, Tatsuomi Kuranobu, Kazutoshi Yukawa, Hirofumi Watanabe, Katsuhiro Oi, Tomohiro Sugimoto, Sho Mokuda, Takaki Nojima, Shintaro Hirata, Eiji Sugiyama
-
Journal Title
Modern Rheumatology
Volume: 31
Issue: 3
Pages: 643-648
DOI
Related Report
Peer Reviewed
-
-
-
-
[Journal Article] Serum CXCL10 levels are associated with better responses to abatacept treatment of rheumatoid arthritis.2020
Author(s)
Yukawa K, Mokuda S, Kohno H, Oi K, Kuranobu T, Tokunaga T, Yoshida Y, Yamana J, Iwahashi M, Hirata S, Yamana S, Sugiyama E.
-
Journal Title
Clinical and Experimental Rheumatology
Volume: -
Related Report
Peer Reviewed
-
-
[Journal Article] Wwp2 maintains cartilage homeostasis through regulation of Adamts5.2019
Author(s)
Mokuda S, Nakamichi R, Matsuzaki T, Ito Y, Sato T, Miyata K, Inui M, Olmer M, Sugiyama E, Lotz M, Asahara H,
-
Journal Title
Nature Communications
Volume: 10
Pages: 2429-2429
Related Report
Peer Reviewed / Open Access / Int'l Joint Research